With John Wiggins’ two sons interested in farming and seeing an opportunity to diversify from his tobacco and row crops, hemp looked like a sure bet to add onto their south Graves County operation. “It fit our niche,” Wiggins said. So last season they decided to grow 128 acres of hemp and joined up with processor GenCanna as a contract farmer.
During a presentation Thursday for the International Narcotics Control Board’s (INCB) 2019 annual report, President Cornelis P. de Joncheere discussed the developments taking place with regard to cannabis and synthetic drugs.
Today, we are very pleased that the FDA listened — and are grateful that Commissioner Hahn and the FDA continue to share our industry’s commitment to help farmers farm this versatile crop and provide global access to reliable and compliant food grade hemp-derived products.
We built GenCanna to provide a consistent, scalable, sustainable supply of premium CBD. Quality and safety have been the bedrock of our company since the outset. We built the GenCanna Production Platform™ (GPP) because of our stubborn focus on manufacturing high quality cannabis at true global scale. We have growing concern over the current CBD isolate market. We have come to learn that there are many fraudulent brokers and re-sellers of CBD isolate misrepresenting their product as GenCanna isolate. We certainly are concerned about the commercial implications of bad actors hurting our brand and bottom-line. But, this is not our primary concern. Our primary concern is for consumers. Our significant investment in quality starts with an understanding that if you are not producing CBD isolate at the international food safety standards that mature food and nutraceutical companies currently meet, then [...]